Monographie - Ceftobiprole medocaril sodium

Son güncelleme :
16/12/2025

Ceftobiprole medocaril sodium

Kimyasal yapı

Ticari isim

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Adaluzis	İrlanda
Mabelio	Fransa
Zevtera	Almanya, Büyük Britanya, Finlandiya, İspanya, İsveç, İsviçre, Meksika, Norveç, Peru

Kaynaklar : Ceftobiprole medocaril sodium

	tip	yayın
2269	Dergi	Chan P, Bishop A, Kupiec TC, Trissel LA, Gole D, Jimidar IM, Vermeersch H. Compatibility of ceftobiprole medocaril with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 2008 ; 65, 16: 1545-1551.
3520	Laboratuar	Cidomycin - Summary of product Chracteristics. Sanofi 2011
3549	Laboratuar	Amikacine B Braun - Résumé des caractéristiques du produit. B Braun 2012
3643	Laboratuar	Gentamicin sulphate (Cidomycin®) - Summary of Product Characteristics Sanofi 2015
3674	Laboratuar	Erythromycin lactobionate - Summary of Product Characteristics PanPharma 2016
4650	Laboratuar	Ceftobiprole (Zevtera 500 mg powder for concentrate for solution for infusion.) Summary of Product Characteristics, Advanz Pharma updated 4 aug 2021. Advanz Pharma 2021
5098	Dergi	Esteban‑Cartelle B, Anaya B.J, Menéndez‑Conde C.P, Vicente‑Oliveros N , Serrano D.R, Álvarez‑Díaz A. Stability of Ceftobiprole Medocaril in Portable Elastomeric Infusion Devices. Infect Dis Ther 2025 ; 14:1685–1696.

Mentions Légales